ATE183639T1 - Zusammensetzung zur verwendung in der transdermalen verabreichung - Google Patents

Zusammensetzung zur verwendung in der transdermalen verabreichung

Info

Publication number
ATE183639T1
ATE183639T1 AT92905485T AT92905485T ATE183639T1 AT E183639 T1 ATE183639 T1 AT E183639T1 AT 92905485 T AT92905485 T AT 92905485T AT 92905485 T AT92905485 T AT 92905485T AT E183639 T1 ATE183639 T1 AT E183639T1
Authority
AT
Austria
Prior art keywords
composition
biologically active
active agent
transdermal administration
carrier
Prior art date
Application number
AT92905485T
Other languages
English (en)
Inventor
Reginald Morton Taylor
David John Wilson
Original Assignee
Commw Scient Ind Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/795,499 external-priority patent/US5308621A/en
Application filed by Commw Scient Ind Res Org filed Critical Commw Scient Ind Res Org
Application granted granted Critical
Publication of ATE183639T1 publication Critical patent/ATE183639T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92905485T 1991-02-18 1992-02-18 Zusammensetzung zur verwendung in der transdermalen verabreichung ATE183639T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPK465191 1991-02-18
AUPK784891 1991-08-19
AUPK784691 1991-08-19
AUPK784791 1991-08-19
US07/795,499 US5308621A (en) 1991-02-18 1991-11-21 Ascorbic acid composition and transdermal administration method

Publications (1)

Publication Number Publication Date
ATE183639T1 true ATE183639T1 (de) 1999-09-15

Family

ID=27507420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92905485T ATE183639T1 (de) 1991-02-18 1992-02-18 Zusammensetzung zur verwendung in der transdermalen verabreichung

Country Status (7)

Country Link
EP (1) EP0572494B1 (de)
JP (1) JPH06508100A (de)
AT (1) ATE183639T1 (de)
AU (1) AU668679B2 (de)
CA (1) CA2103725C (de)
DE (1) DE69229857T2 (de)
WO (1) WO1992014442A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2122585A1 (en) * 1991-12-13 1993-06-24 Martin J. Griffin Transdermal azidothymidine
DE4329446A1 (de) * 1993-09-01 1995-03-02 Basf Ag Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
US6103267A (en) * 1998-07-27 2000-08-15 Sunsmart, Inc. Stabilized ascorbic acid, composition, and method of use
JP2003040763A (ja) * 2001-05-23 2003-02-13 Taisho Pharmaceut Co Ltd 多価アルコール含有軟膏剤基剤
DE10237057A1 (de) * 2002-08-09 2004-03-25 Grünenthal GmbH Opioid-Rezeptor-Antagonisten in Pflasterformulierungen
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
ES2562878T3 (es) 2007-05-25 2016-03-08 Indivior Uk Limited Formulaciones de liberación sostenida de compuestos de risperidona
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR751951A (fr) * 1933-03-02 1933-09-13 Procédé d'hydrophilisation des corps gras
FR948326A (fr) * 1947-06-24 1949-07-28 Brillantine à base d'hormones
US4156736A (en) * 1976-05-28 1979-05-29 Sanol Schwarz-Monheim Gmbh Supersaturated isosorbide dinitrate solution, process for its production and its use
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition
GB2156215B (en) * 1984-03-05 1988-03-02 Nitto Electric Ind Co Percutaneous absorption type adhesive pharmaceutical preparation
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
JPH066534B2 (ja) * 1986-10-09 1994-01-26 積水化学工業株式会社 経皮吸収貼付剤
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US5110606A (en) * 1990-11-13 1992-05-05 Affinity Biotech, Inc. Non-aqueous microemulsions for drug delivery

Also Published As

Publication number Publication date
CA2103725C (en) 2002-06-04
EP0572494B1 (de) 1999-08-25
WO1992014442A1 (en) 1992-09-03
CA2103725A1 (en) 1992-08-19
EP0572494A4 (en) 1996-05-29
JPH06508100A (ja) 1994-09-14
DE69229857D1 (de) 1999-09-30
EP0572494A1 (de) 1993-12-08
AU668679B2 (en) 1996-05-16
DE69229857T2 (de) 2000-04-20
AU1272392A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
DE69229857D1 (de) Zusammensetzung zur verwendung in der transdermalen verabreichung
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
MY125556A (en) Aqueous formulations of peptide
KR910015298A (ko) 오메프라졸 직장투여조성물
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
DE68921814D1 (de) VIP-Konjugate und deren aktive Fragmente mit hydrophoben Anteilen und topische Zuberetungen zur Verwendung in der Behandlung männlicher Impotenz.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
KR927003079A (ko) 골격 치유방법 및 치료용 조성물
PH22556A (en) Heterocyclic compounds, pharmaceutical compositions containing the same and method of use thereof
YU48766B (sh) Postupak za dobijanje farmaceutskog preparata za oralnu primenu sa usporenim oslobađanjem aktivne supstance bez rastvarača
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
FI980471L (fi) 1,3-substituoidut sykloalkeenit ja sykloalkaanit keskushermostoon vaikuttavina aineina
PH23003A (en) Piroxicam monohydrate and aqueous pharmaceutical formulations containing same
HUT57203A (en) Process for substituted benzimidazol and paharmaceutical composition containing them
EP0173664A3 (de) Biologisch aktive Benzimidazolderivate und Verfahren zu ihrer Herstellung
UA37206C2 (uk) Фармацевтична композиція, яка містить алкілсульфонамід-агоніст 5нті- подібного рецептора для ректального введення
SE8600496D0 (sv) Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
DK78487A (da) Farmaceutisk praeparat indeholdende et i vand kvaeldende polymermateriale
FR2684878B1 (fr) Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
ATE238063T1 (de) Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor
KR880004810A (ko) 소화성 궤양 치료제
Iwata et al. Interaction between thymopoietin and facteur thymique serique in the rosette inhibition assay
DK0741579T3 (da) Vandig formulering med forhalet frigivelse
KR900017599A (ko) 종양 치료용 약학 조성물
FR2585020B1 (fr) Nouvelle substance biologiquement active, appelee girolline, extraite de l'eponge pseudaxinyssa cantharella, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties